ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Resmed Inc

Resmed Inc (0KW4)

102.85
0.00
(0.00%)
終了 1月15日 1:30AM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
102.85
買値
0.00
売値
0.00
出来高
150
0.00 日の範囲 0.00
102.85 52 週間の範囲 102.85
時価総額
前日終値
102.85
始値
-
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
864
発行済株式数
146,907,000
配当利回り
-
PER
32.93
1 株当たり利益 (EPS)
6.95
歳入
4.69B
純利益
1.02B

Resmed Inc について

セクター
Surgical,med Instr,apparatus
業界
Surgical,med Instr,apparatus
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Resmed Inc is listed in the Surgical,med Instr,apparatus sector of the ロンドン証券取引所 with ticker 0KW4. The last closing price for Resmed was US$102.85. Over the last year, Resmed shares have traded in a share price range of US$ 102.85 to US$ 102.85.

Resmed currently has 146,907,000 shares in issue. The market capitalisation of Resmed is US$15.11 billion. Resmed has a price to earnings ratio (PE ratio) of 32.93.

0KW4 最新ニュース

Vaping Expected to Increase COPD Health and Economic Burden by 2050

Vaping Expected to Increase COPD Health and Economic Burden by 2050 New ResMed-supported research presented at ERS 2024 projects future Chronic Obstructive Pulmonary Disease (COPD) burden in...

PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia

PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia ResMed studies presented at SLEEP 2024 also revealed a 17% prevalence...

ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis

ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis 36,000 people across 17 markets responded to the company’s fourth annual survey.40% of respondents get no more than three...

ResMed Adopts New Operating Model to Accelerate Long-term Growth

ResMed Adopts New Operating Model to Accelerate Long-term Growth Justin Leong appointed Chief Product Officer, effective immediately.Katrin Pucknat appointed Chief Marketing Officer...

ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software

ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software Expands ResMed’s sleep management software solution, will help sleep labs and physicians more...

PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP

PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP The studies also showed 18-40% lower costs incurred from ER...

3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023

3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023 France’s Jean-Louis Pépin and Germany’s Holger Woehrle presented studies in which treating OSA with CPAP...

ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer

ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer Rider and Haake, both internal promotions, joined ResMed’s executive team on May...

ResMed Chief Administrative Officer and Global General Counsel to Retire

ResMed Chief Administrative Officer and Global General Counsel to Retire ResMed to conduct an internal search for a successor general counselAmy Wakeham appointed Chief Communications and...

ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep

ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep 81% of respondents experience one or more symptoms indicating poor...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
100102.85102.85102.85164102.85DE
400102.85102.85102.851006102.85DE
1200102.85102.85102.85864102.85DE
2600102.85102.85102.851157102.85DE
5200102.85102.85102.851258102.85DE
15600102.85102.85102.851697102.85DE
26000102.85102.85102.851110102.85DE

0KW4 - Frequently Asked Questions (FAQ)

What is the current Resmed share price?
The current share price of Resmed is US$ 102.85
How many Resmed shares are in issue?
Resmed has 146,907,000 shares in issue
What is the market cap of Resmed?
The market capitalisation of Resmed is USD 15.11B
What is the 1 year trading range for Resmed share price?
Resmed has traded in the range of US$ 102.85 to US$ 102.85 during the past year
What is the PE ratio of Resmed?
The price to earnings ratio of Resmed is 32.93
What is the cash to sales ratio of Resmed?
The cash to sales ratio of Resmed is 7.17
What is the reporting currency for Resmed?
Resmed reports financial results in USD
What is the latest annual turnover for Resmed?
The latest annual turnover of Resmed is USD 4.69B
What is the latest annual profit for Resmed?
The latest annual profit of Resmed is USD 1.02B
What is the registered address of Resmed?
The registered address for Resmed is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Resmed website address?
The website address for Resmed is www.resmed.com
Which industry sector does Resmed operate in?
Resmed operates in the SURGICAL,MED INSTR,APPARATUS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
TRLSTrellus Health Plc
4.95p
(725.00%)
201.06M
ALKAlkemy Capital Investments Plc
172.50p
(32.69%)
271.97k
PYCPhysiomics Plc
1.00p
(29.03%)
35.26M
NFXNuformix Plc
0.06p
(26.32%)
222.6M
FOGFalcon Oil & Gas Ltd.
7.25p
(23.93%)
765.79k
THRUThruvision Group Plc
3.00p
(-53.85%)
284.85k
MRITMerit Group Plc
17.50p
(-42.62%)
106.32k
RCGHRc365 Holding Plc
2.25p
(-35.16%)
29.28M
BLUBlue Star Capital Plc
5.75p
(-30.30%)
1.17M
MOSMobile Streams Plc
0.34p
(-27.66%)
93.28M
TRPTower Resources Plc
0.034p
(-4.23%)
1.36B
MSMNMosman Oil And Gas Limited
0.0325p
(6.56%)
570.69M
SYMESupply@me Capital Plc
0.0032p
(-13.51%)
339.48M
ENETEthernity Networks Ltd
0.12p
(6.67%)
314.93M
NTVONativo Resources Plc
0.0019p
(-5.00%)
304.91M